• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Update on biomarkers of bicuspid aortic disease: still a long road to run?

作者信息

Della Corte Alessandro, Lo Presti Federica, Pacini Davide

机构信息

Unit of Cardiac Surgery, Monaldi Hospital, Department of Translational Medical Sciences, University of Campania "L. Vanvitelli", Naples, Italy.

Heart and Vessels Department, Casa di Cura San Michele, Maddaloni, Italy.

出版信息

Ann Cardiothorac Surg. 2022 Jul;11(4):465-467. doi: 10.21037/acs-2021-bav-12.

DOI:10.21037/acs-2021-bav-12
PMID:35958540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9357967/
Abstract
摘要

相似文献

1
Update on biomarkers of bicuspid aortic disease: still a long road to run?二叶式主动脉疾病生物标志物的最新进展：仍有很长的路要走？
Ann Cardiothorac Surg. 2022 Jul;11(4):465-467. doi: 10.21037/acs-2021-bav-12.
2
Update on bicuspid aortic valve aortopathy.二叶式主动脉瓣主动脉病变的最新进展。
Curr Opin Cardiol. 2017 Nov;32(6):651-654. doi: 10.1097/HCO.0000000000000456.
3
Update in Biomolecular and Genetic Bases of Bicuspid Aortopathy.二叶式主动脉病变的生物分子与遗传基础的最新研究进展。
Int J Mol Sci. 2021 May 27;22(11):5694. doi: 10.3390/ijms22115694.
4
Marfan Syndrome Versus Bicuspid Aortic Valve Disease: Comparative Analysis of Obstetric Outcome and Pregnancy-Associated Immediate and Long-Term Aortic Complications.马凡综合征与二叶式主动脉瓣疾病：产科结局及妊娠相关即刻和长期主动脉并发症的对比分析
J Clin Med. 2020 Apr 15;9(4):1124. doi: 10.3390/jcm9041124.
5
Bicuspid aortic valve-associated aortopathy: update on biomarkers.二叶式主动脉瓣相关主动脉病变：生物标志物的最新进展
Curr Opin Cardiol. 2018 Mar;33(2):134-139. doi: 10.1097/HCO.0000000000000481.
6
Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results.升主动脉手术中保留二叶式主动脉根部：长期结果的最新情况
J Thorac Dis. 2017 Jun;9(6):1634-1638. doi: 10.21037/jtd.2017.05.83.
7
Aortic valve-sparing root replacement in patients with bicuspid aortic valve: long-term outcome with the David I procedure over 20 years.二叶式主动脉瓣患者的保留主动脉瓣根部置换术：David I手术20多年的长期结果
Eur J Cardiothorac Surg. 2020 Jul 1;58(1):86-93. doi: 10.1093/ejcts/ezaa083.
8
Bicuspid Aortic Valve: An Update in Morphology, Genetics, Biomarker, Complications, Imaging Diagnosis and Treatment.二叶式主动脉瓣：形态学、遗传学、生物标志物、并发症、影像诊断及治疗的最新进展
Front Physiol. 2019 Jan 30;9:1921. doi: 10.3389/fphys.2018.01921. eCollection 2018.
9
Novel Approaches for BAV Aortopathy Prediction-Is There a Need for Cohort Studies and Biomarkers?新型方法预测 BA V 主动脉病——是否需要队列研究和生物标志物？
Biomolecules. 2018 Jul 19;8(3):58. doi: 10.3390/biom8030058.
10
Bicuspid aortic valve and associated aortopathy: an update.二叶式主动脉瓣及相关主动脉病变：更新。
Semin Thorac Cardiovasc Surg. 2013 Winter;25(4):310-6. doi: 10.1053/j.semtcvs.2014.01.004. Epub 2014 Jan 24.

本文引用的文献

1
MicroRNAs involve in bicuspid aortic aneurysm: pathogenesis and biomarkers.微小 RNA 参与二叶式主动脉瘤：发病机制和生物标志物。
J Cardiothorac Surg. 2021 Aug 12;16(1):230. doi: 10.1186/s13019-021-01613-9.
2
The science of BAV aortopathy.升主动脉瘤病变的科学。
Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):465-474. doi: 10.1016/j.pcad.2020.06.009. Epub 2020 Jun 26.
3
Expression Patterns of Circulating MicroRNAs in the Risk Stratification of Bicuspid Aortopathy.循环微小RNA在二叶式主动脉病变风险分层中的表达模式
J Clin Med. 2020 Jan 19;9(1):276. doi: 10.3390/jcm9010276.
4
Risk Stratification in Bicuspid Aortic Valve Aortopathy: Emerging Evidence and Future Perspectives.二叶式主动脉瓣主动脉病变的危险分层：新出现的证据和未来展望。
Curr Probl Cardiol. 2021 Mar;46(3):100428. doi: 10.1016/j.cpcardiol.2019.06.002. Epub 2019 Jun 21.
5
The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-related aortopathy: Full online-only version.美国胸外科学会关于二叶式主动脉瓣相关主动脉病变的共识指南：全文仅在线版。
J Thorac Cardiovasc Surg. 2018 Aug;156(2):e41-e74. doi: 10.1016/j.jtcvs.2018.02.115.
6
Candidate plasma biomarkers for predicting ascending aortic aneurysm in bicuspid aortic valve disease.用于预测二叶式主动脉瓣疾病中升主动脉瘤的候选血浆生物标志物。
J Cardiothorac Surg. 2018 Jun 22;13(1):76. doi: 10.1186/s13019-018-0762-1.
7
A Possible Early Biomarker for Bicuspid Aortopathy: Circulating Transforming Growth Factor β-1 to Soluble Endoglin Ratio.可能用于二叶式主动脉瓣病变的早期生物标志物：循环转化生长因子 β-1 与可溶性内皮糖蛋白比值。
Circ Res. 2017 May 26;120(11):1800-1811. doi: 10.1161/CIRCRESAHA.117.310833. Epub 2017 Apr 18.
8
miRs, miRs in the Wall, Who Is the Most Causative of Them All?
J Am Coll Cardiol. 2016 Jun 28;67(25):2978-80. doi: 10.1016/j.jacc.2015.12.078.
9
The conundrum of aortic dissection in patients with bicuspid aortic valve: the tissue, the mechanics and the mathematics.二叶式主动脉瓣患者主动脉夹层的难题：组织、力学与数学
Eur J Cardiothorac Surg. 2015 Jul;48(1):150-1. doi: 10.1093/ejcts/ezu418. Epub 2014 Oct 28.
10
Circulating soluble receptor for advanced glycation end product identifies patients with bicuspid aortic valve and associated aortopathies.循环晚期糖基化终末产物可溶性受体可识别二叶式主动脉瓣及相关主动脉病变患者。
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2349-57. doi: 10.1161/ATVBAHA.114.303784. Epub 2014 Aug 14.